Description
FGF-4 Monoclonal Antibody
| Catalog number: | B2015314 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 g |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | FGF-4 Monoclonal antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Nakazawa N, Taniwaki M, Yawata Y, Ueki A. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation Int J Oncol. 1999 Dec;15(6):1205-12.
- Hannon K, Kudla AJ, McAvoy MJ, Clase KL, Olwin BB. Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms J Cell Biol. 1996 Mar;132(6):1151-9.
- Shimon I, Hinton DR, Weiss MH, Melmed S. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness Clin Endocrinol (Oxf). 1998 Jan;48(1):23-9.
- Matsumoto-Yoshitomi S, Kuroshima K, Nomura C, Habashita J, Kurokawa T. Construction of a sensitive enzyme immunoassay for human fibroblast growth factor 9 Hybridoma. 1996 Aug;15(4):299-305.
- Hernndez-Bedolla MA, Carretero-Ortega J, Valadez-Snchez M, Vzquez-Prado J, Reyes-Cruz G. Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells Biochim Biophys Acta. 2015 Jan;1853(1):166-82.
- Hasan S, Koda T, Kakinuma M. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells J Biol Chem. 1994 Oct 7;269(40):25042-8.
- Hajitou A, Deroanne C, Nol A, Collette J, Nusgens B, Foidart JM, Calberg-Bacq CM. Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4 Breast Cancer Res Treat. 2000 Mar;60(1):15-28.
- Ramrez-Vlez R, Garca-Hermoso A, Correa-Rodrguez M, Fernndez-Irigoyen J, Palomino-Echeverra S, Santamara E, Correa-Bautista JE, Gonzlez-Ruz K, Izquierdo M. Effects of Different Doses of Exercise on Inflammation Markers Among Adolescents With Overweight/Obesity: HEPAFIT Study J Clin Endocrinol Metab. 2022 May 17;107(6):e2619-e2627.
- Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells Biochem J. 2003 Oct 1;375(Pt 1):199-205.
